US to diversify infant formula industry to avoid shortages
The Biden administration is looking to help foreign manufacturers of baby formula stay on the U.S. market for the long term
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The Biden administration is looking to help foreign makers of baby formula stay on the U.S. market for the long term, in an effort to diversify the industry after the closure of the largest domestic plant sparked a nationwide shortage.
The Food and Drug Administration on Wednesday was set to announce plans to help overseas producers that have sent supplies to the United States, under emergency approval to address the shortfall, secure long-term authorization to market their formula in the U.S.
The agency will provide a way for producers temporarily selling in the U.S. to meet existing regulatory requirements so they can stay on the market, providing consumers with more choices and making supplies more resilient against current and future shortages.
The FDA will also host meetings and provide producers with a single point of contact to work through the regulatory system to make the application process more efficient.